Greenwich LifeSciences, Inc.
GLSI$101M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaSTAFFORD
Drugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Dec 15, 2026
43wMarket Overview
Stock performance and key metrics
GLSI News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations |
|---|---|---|---|
GLSI-100 | Phase 3 | Breast Cancer | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply